https://www.news-medical.net/news/20091030/Bayer-HealthCares-Phase-II-study-results-of-imaging-agent-florbetaben.aspx
Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid...
phase ii studybayer healthcareimaging agentresults
https://www.prnewswire.com/news-releases/trace-biosciences-announces-fda-ind-clearance-for-first-nerve-specific-imaging-agent-302675689.html
/PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced that the U.S. Food...
tracebiosciencesannouncesfdaind
https://pubmed.ncbi.nlm.nih.gov/3002999/
In our search for a technetium-tumor seeking agent, the chemical characteristic of polynuclear Ga-citrate attracted our attention. On this basis, we selected...
designpentavalentcomplex
https://www.prnewswire.com/news-releases/iba-molecular-piramal-imaging-sign-agreement-for-new-f-18-amyloid-imaging-agent-165114976.html
/PRNewswire/ -- IBA Molecular and Piramal Imaging SA (Piramal) have announced an agreement whereby IBA Molecular will manufacture and distribute...
sign agreementibamolecularpiramalimaging
https://www.techtarget.com/pharmalifesciences/news/366608418/FDA-Approves-New-Imaging-Agent-for-Prostate-Cancer
On September 27, 2022, the FDA approved a new drug application for 18F-rhPSMA-7.3, an imaging agent to detect prostate cancers.
imaging agentprostate cancerfdanewtechtarget
https://www.medtechdive.com/news/GE-Healthcare-FDA-approval-cardiac-PET-imaging-agent/728550/
Called Flyrcado, the radiotracerĀ could help improve cardiac imaging accuracy in patients with a high body mass index and women, the company said.
ge healthcarenew petimaging agentgetsfda
https://www.preprints.org/manuscript/202503.0667
Recent advancements in phototherapy have underscored the need for effective cellular imaging agents that can enhance therapeutic efficacy and precision....
perylene diimidecellular imagingroledyes